Sagimet Biosciences gives going public a second chance under new CEO
June 23, 2023 at 19:52 PM EDT
Biotech drug developer Sagimet Biosciences is taking another shot at going public, according to a filing with the SEC late Friday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|